The laboratories at Integral Molecular are presently operating in a modified capacity to ensure the well-being of our staff and community. Our current operations focus on customer projects and research to combat COVID-19.
Our President Ben Doranz spoke with Technical.ly Philly about Integral Molecular's role in the accelerating research for COVID-19 vaccines and therapeutics.
Integral Molecular provides solutions for antibody discovery against membrane protein targets, including GPCRs, ion channels, transporters, and viruses.